Commentary Open Access
Volume 7 | Issue 1 |
Near-point-of-care molecular HPV diagnostics: Pathways to scalable cervical-cancer screening in low-and middle-income countries
Minal Dakhave1,*, Amrita Khaire2
- 1Dognosis India Private Limited, Rajajinagar Malleswaram, West Bangalore, Karnataka, India 560055
- 2InnoScientica Research Private Limited, Pune, Maharashtra, India, 411046
Corresponding Author
Minal Dakhave, minaldakhave@gmail.com
Received Date: December 04, 2025
Accepted Date: December 29, 2025
Dakhave M, Khaire A. Near-point-of-care molecular HPV diagnostics: Pathways to scalable cervical-cancer screening in low- and middleincome countries. J Allergy Infect Dis. 2026;7(1):10-16.
Copyright: © 2026 Dakhave M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Osteoarthritis in older adults: Disability associations and the corona virus
Background: Osteoarthritis, a widespread highly painful oftentimes incapacitating joint disease continues to impose immense personal and societal challenges among adults of all ages, especially older adults.
Objective: This review aimed to describe the extent to which older adults with osteoarthritis may suffer excess disability, compared to healthy age-matched older adults, and why this is important to note and prevent in the context of the novel COVID-19 corona virus pandemic.
CRISPR-Cas systems: A revolution in genome editing and its diverse applications
The clustered regularly interspaced short palindromic repeats (CRISPR) Cas (CRISPR6 associated protein) system is an advanced adaptive immune system found in prokaryotes. First discovered in1987, CRISPR Cas has revolutionized genetic research in the past two decades. CRISPR-Cas9 the most widespread system enables precise gene editing by creating double strand breaks.
Near-point-of-care molecular HPV diagnostics: Pathways to scalable cervical-cancer screening in low-and middle-income countries
Cervical cancer remains a leading cause of preventable death among women. Around 660,000 new cases and 350,000 deaths were reported in 2022. Most of these cases and deaths occurred in low- and middle-income countries. Persistent infection with oncogenic human papillomavirus (HPV) genotypes is an important cause of almost all cervical cancers.